Belgium is a well-established hub for pharmaceutical development and manufacturing within Europe. CDMO companies in Belgium are strategically integrated into the global life sciences ecosystem, offering expertise in clinical trial supply, commercial manufacturing, and regulatory support aligned with EMA standards.
From innovative biotech start-ups to global pharmaceutical leaders, companies choose CDMOs in Belgium for their compliance with European regulations, advanced infrastructure, and ability to scale efficiently across international markets.
Why Choose CDMOs in Belgium?
Belgium has built a strong reputation for its advanced pharmaceutical infrastructure and central role in European healthcare systems. CDMOs in Belgium benefit from collaborations with world-class academic and research centers, proximity to EMA regulatory networks, and access to EU innovation funding programs.
With extensive experience in complex drug development and accelerated EU regulatory pathways, CMOs in Belgium are ideal partners for companies seeking efficient market entry and expansion in Europe.
Key Services Offered by CDMO Companies in Belgium
- Clinical Supply Manufacturing: Phase I–III production with rapid scale-up and EU-wide distribution capabilities.
- Regulatory & Submission Support: Expertise in EMA submissions, including IMPD and MAA dossiers.
- High-Containment and Specialty Manufacturing: Facilities equipped for potent APIs, sterile injectables, and complex formulations.
- Integrated Packaging and Labeling: GMP-compliant packaging with serialization and temperature-controlled logistics for European distribution.
- Tech Transfer & Commercial Readiness: Seamless transitions from development to launch with validated processes and commercial-scale support.
Advantages of Partnering with CDMOs in Belgium
- Regulatory Alignment: Direct compliance with EMA requirements for faster approvals and smooth audits.
- Strategic EU Market Access: Belgium offers a central location and logistics advantage for pan-European and global distribution.
- Skilled Workforce: Highly trained professionals in pharma manufacturing, biotechnology, and regulatory sciences.
- Robust Infrastructure: State-of-the-art facilities designed for innovation, flexibility, and large-scale production.
- Trusted Collaborations: Strong track record of partnerships with European and international pharma companies.
CDMO Companies in Belgium
Some of the leading C(D)MO companies in Belgium include:
- Cenexi: Belgian CDMO located 20 km south of Brussels with 340 employees. It specializes in the production of sterile, highly potent injectables, mainly for oncology applications. [See CDMO profile]
- Cambrex: CDMO in Belgium strategically located in the Liège region. Their state-of-the-art cGMP facility provides ICH and custom conditions to meet specific storage requirements of any pharmaceutical project, from -80°C up to +50°C, with full humidity control. [See CDMO profile]
- White Raven: Fill and finish site dedicated to GMP formulation and aseptic filling of sterile liquid injectables. [See CDMO profile]
- Ardena: Drug product formulation development and GMP manufacturing for clinical-phase products. [See CDMO profile]
Related Information
Let MAI CDMO Network Help You Find the Right Belgium CDMO Partner
Navigating the Belgian CDMO landscape requires market knowledge and trusted connections. MAI CDMO helps you identify the most suitable CDMO companies in Belgium—with the regulatory expertise, capacity, and technical skills to accelerate your project.
From early clinical batches to commercial scale production, our tailored matchmaking ensures you find a CDMO in Belgium that aligns with your objectives and timelines.
Partnering with Contact MAI CDMO Network today and discover the right CDMO in Belgium to support your product journey—from lab to launch.